Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Clinical research sponsor
Clinical trials
60 shownTranscutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor AgonistsNCT07619989 · lead sponsor · 2026-08-01
RECRUITINGIpsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer DiagnosisNCT07795723 · lead sponsor · 2026-07-20
RECRUITINGAdjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical ProstatectomyNCT07711314 · lead sponsor · 2026-07-01
RECRUITINGA Study of Metformin to Improve Cardiac Function After LVAD ImplantationNCT07666698 · lead sponsor · 2026-07-01
RECRUITINGThe Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive ImpairmentNCT07650318 · lead sponsor · 2026-06-01
RECRUITINGDiagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLDNCT07632677 · lead sponsor · 2026-05-15
RECRUITINGTranscutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle InterventionNCT07630597 · lead sponsor · 2026-05-08
RECRUITINGAI-Assisted Remote Insulin Pump Optimization in T1DMNCT07732777 · lead sponsor · 2026-01-28
RECRUITINGFood Intake-Related Brain and Metabolic Responses in ObesityNCT07392905 · lead sponsor · 2025-12-21
RECRUITINGMazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)NCT07083154 · lead sponsor · 2025-09-27
RECRUITINGEvaluating Anti-Obesity Medications 6 Months After Metabolic SurgeryNCT07163650 · lead sponsor · 2025-09-16
RECRUITINGMulticenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin TabletsNCT07023172 · lead sponsor · 2025-05-30
RECRUITINGAutologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy HistoryNCT06821685 · lead sponsor · 2025-02-13
RECRUITINGLiraglutide in Preventing Delirium in Diabetic Elderly After Cardiac SurgeryNCT06361238 · lead sponsor · 2024-11-19
RECRUITINGDiagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate CancerNCT06584279 · lead sponsor · 2024-10-01
RECRUITINGRadiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPCNCT06992232 · lead sponsor · 2024-08-01
RECRUITINGSalvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate CancerNCT06305832 · lead sponsor · 2023-09-07
RECRUITINGImmunotherapy with Autologous Tregs in T1DMNCT06708780 · lead sponsor · 2023-04-12
RECRUITINGRezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate CancerNCT05753566 · lead sponsor · 2023-03-01
RECRUITINGLong-Term Survival After LVAD Implantation in End-Stage Heart FailureNCT07382284 · lead sponsor · 2022-07-17
RECRUITINGRisk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLDNCT05766449 · lead sponsor · 2022-06-01
RECRUITINGEstablish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma BiomarkersNCT06561906 · lead sponsor · 2020-09-01
RECRUITINGNeoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate CancerNCT05406999 · lead sponsor · 2020-02-01
RECRUITINGChina Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)NCT06650969 · lead sponsor · 2016-10-01
RECRUITINGSafety, Tolerability, Immunogenicity, Pharmacodynamic Characteristics, and Preliminary Anti-tumor Activity of Personalized Cancer Vaccines Alone and in Combination With Toripalimab in Participants With Resected NSCLCNCT07683832 · lead sponsor · 2026-07-28
NOT_YET_RECRUITING177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical TrialNCT07677566 · lead sponsor · 2026-07-01
NOT_YET_RECRUITINGTranscutaneous Auricular Vagus Nerve Stimulation in Type 2 Diabetes With Mild Cognitive ImpairmentNCT07642518 · lead sponsor · 2026-05-20
NOT_YET_RECRUITINGa Salivary Cell-free RNA Liquid Biopsy Model for Non-invasive Diagnosis in Sjögren's DiseaseNCT07824440 · lead sponsor · 2026-01-01
COMPLETEDAI-Based Ultrasound Prediction Model for Intracranial Pressure and Prognosis in Lung Cancer Patients With Leptomeningeal Metastasis: A Dual-Center StudyNCT07005791 · lead sponsor · 2025-07-01
NOT_YET_RECRUITINGEffects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver DiseaseNCT07274644 · lead sponsor · 2025-03-29
ACTIVE_NOT_RECRUITINGObserving the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate CancerNCT07721532 · lead sponsor · 2025-01-08
ACTIVE_NOT_RECRUITINGStudying the Senescent T Cell Features and Its Relationship with the Chemotherapy Efficacy in Young TNBCNCT06684054 · lead sponsor · 2025-01-01
NOT_YET_RECRUITINGClinical Classification and Imaging Markers in Patients of ObesityNCT06649071 · lead sponsor · 2024-10-20
ENROLLING_BY_INVITATIONEvaluate the Efficacy and Safety of SASI Compared with RYGB in the Treatment of Obesity and Related Metabolic DiseasesNCT06598267 · lead sponsor · 2024-09-03
ACTIVE_NOT_RECRUITINGThe Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes MellitusNCT06546436 · lead sponsor · 2024-08-15
NOT_YET_RECRUITINGImmunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung CancerNCT06391008 · lead sponsor · 2024-04-30
UNKNOWNEffects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical TrialNCT06085703 · lead sponsor · 2024-04-01
COMPLETEDThe Clinical Efficacy and Safety of Finerenone in the Treatment of Primary AldosteronismNCT06381323 · lead sponsor · 2024-03-01
COMPLETEDSafety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological TumorsNCT06221774 · lead sponsor · 2024-02-01
UNKNOWNEffects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive ImpairmentNCT06327633 · lead sponsor · 2024-01-01
COMPLETEDResearch on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic SurgeryNCT07374445 · lead sponsor · 2023-09-01
COMPLETEDComparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary AldosteronismNCT05814770 · lead sponsor · 2023-05-01
UNKNOWNUltrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node MetastasisNCT05768451 · lead sponsor · 2023-04-01
UNKNOWNAdjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)NCT05778097 · lead sponsor · 2023-04-01
NOT_YET_RECRUITINGStandard Therapy and TIPS for Moderate to High-risk Esophageal and Gastric Variceal BleedingNCT06013670 · lead sponsor · 2023-01-01
UNKNOWNEstablish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive ImpairmentNCT05543967 · lead sponsor · 2022-10-18
UNKNOWNRelationship and Central Mechanism Between Diabetes and Cognitive Impairment Based on Simultaneous EEG-fMRI Approach and Peripheral Neuropathology Biomarkers AssayNCT05545657 · lead sponsor · 2022-10-18
UNKNOWNLIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 DiabetesNCT05313529 · lead sponsor · 2022-10-08
COMPLETEDRisk Model of Cognitive Impairment in DiabetesNCT05590442 · lead sponsor · 2022-09-01
UNKNOWNThe Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate CancerNCT05461261 · lead sponsor · 2022-07-01
UNKNOWNEarly Assessment of Impaired Cardiac Function in Patients With Diabetes MellitusNCT05484817 · lead sponsor · 2022-06-01
UNKNOWNThe Red Blood Cells Based Blood Test for Lung Cancer EARLY DetectionNCT05380999 · lead sponsor · 2022-05-01
UNKNOWNEfficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate CancerNCT05249712 · lead sponsor · 2022-01-01
UNKNOWNWeight Loss Effects of M-health App in Obesity Multidisciplinary Outpatient ClinicNCT05168072 · lead sponsor · 2021-12-10
UNKNOWNClinical Validation of the Prognostic Value of the PrTS on Prostate Cancer PatientsNCT05248282 · lead sponsor · 2021-09-01
UNKNOWNMRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate BiopsyNCT04953351 · lead sponsor · 2021-08-01
UNKNOWNOptimization of the Core Number and Location for Targeted Prostate BiopsyNCT04983706 · lead sponsor · 2021-07-05
UNKNOWNThe Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate CancerNCT04992026 · lead sponsor · 2021-01-01
COMPLETEDSHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate CancerNCT04676607 · lead sponsor · 2020-12-17
COMPLETEDEffectiveness of 68Ga-PSMA PET/MRI for Improving the Detection of csPCa in Lesions With PI-RADS Score 3NCT04573179 · lead sponsor · 2020-07-01
UNKNOWNSponsor roles
lead sponsor79
collaborator28
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.